Morning Light Biotech: Net profit attributable to parent in 2025 is expected to increase by 286.65% year-on-year

Beijing News Shell Finance reported that Chen Guang Biological announced that the company will achieve a total revenue of 6.564 billion yuan in 2025, a decrease of 6.15% year-on-year; net profit attributable to shareholders of the listed company is 364 million yuan, an increase of 286.65% year-on-year.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)